CCIA
AMRI

Campbell & Co Investment Adviser’s Albany Molecular Research Inc AMRI Stock Holding History

Campbell & Co Investment Adviser’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,238
Closed -$158K – 395
2017
Q1 		$158K Buy
+11,238
New +$184K 0.41% 121

Other funds holding AMRI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Campbell & Co Investment Adviser's AMRI Position: Q2 2017 in Review

Campbell & Co Investment Adviser sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 11,238 shares — an estimated $158K sold.

Campbell & Co Investment Adviser first reported a position in AMRI in Q1 2017 and held it in 1 quarter. The position peaked at $158K in Q1 2017. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

  • Campbell & Co Investment Adviser reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 11,238 Albany Molecular Research Inc shares in Q2 2017, an estimated $158K.
  • Campbell & Co Investment Adviser first reported a position in Albany Molecular Research Inc in Q1 2017 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's Albany Molecular Research Inc position peaked at $158K in Q1 2017.
  • 136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2017, filed 26 Jul 2017.